MX2015007885A - Compuestos farmaceuticos. - Google Patents

Compuestos farmaceuticos.

Info

Publication number
MX2015007885A
MX2015007885A MX2015007885A MX2015007885A MX2015007885A MX 2015007885 A MX2015007885 A MX 2015007885A MX 2015007885 A MX2015007885 A MX 2015007885A MX 2015007885 A MX2015007885 A MX 2015007885A MX 2015007885 A MX2015007885 A MX 2015007885A
Authority
MX
Mexico
Prior art keywords
derivatives
pharmaceutical compounds
analogs
therapeutically
diagnosis
Prior art date
Application number
MX2015007885A
Other languages
English (en)
Inventor
Paul Bingham
Lakmal Boteju
Robert Shorr
Robert Rodríguez
Thomas Kwok
James Marecek
Original Assignee
Cornerstone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornerstone Pharmaceuticals Inc filed Critical Cornerstone Pharmaceuticals Inc
Publication of MX2015007885A publication Critical patent/MX2015007885A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Cantidades terapéuticamente efectivas de análogos o derivados de ácidos grasos de alquilo novedosos, tales como, pero no limitado a, ácido lipoico, y formulaciones farmacéuticas que comprenden tales análogos o derivados y portadores farmacéuticamente aceptables para el mismo, son útiles para el tratamiento, la prevención, la formación de imágenes, y/o diagnóstico de trastornos médicos.
MX2015007885A 2012-12-19 2013-12-19 Compuestos farmaceuticos. MX2015007885A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261797945P 2012-12-19 2012-12-19
PCT/US2013/000276 WO2014098926A1 (en) 2012-12-19 2013-12-19 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
MX2015007885A true MX2015007885A (es) 2016-04-28

Family

ID=50978975

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007885A MX2015007885A (es) 2012-12-19 2013-12-19 Compuestos farmaceuticos.

Country Status (11)

Country Link
US (3) US20150322103A1 (es)
EP (1) EP2934542A4 (es)
JP (1) JP6395724B2 (es)
CN (1) CN105142643B (es)
AU (1) AU2013364387B2 (es)
BR (1) BR112015014327A2 (es)
CA (1) CA2895029A1 (es)
HK (1) HK1216619A1 (es)
IL (1) IL239512B (es)
MX (1) MX2015007885A (es)
WO (1) WO2014098926A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263653B2 (en) 2007-04-18 2012-09-11 Cornerstone Pharmaceuticals, Inc. Pharmaceutical formulations containing lipoic acid derivatives
ES2819175T3 (es) 2014-06-19 2021-04-15 Rafael Pharmaceuticals Inc Compuestos farmacéuticos
CA2965898C (en) 2014-06-19 2021-07-06 Robert Shorr Fatty acid analogs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252538B (it) 1991-12-18 1995-06-19 Pirelli Sistemi Antivibranti Organo elestico per la realizzazione di sospensioni
EP1486495B1 (en) 1998-10-26 2009-12-09 The Research Foundation of State University of New York Salts of lipoic acid derivatives and their use in treatment of disease
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
AU2003264412A1 (en) * 2002-09-13 2004-04-30 Oga Research, Incorporated Melanin extinguisher
CN101765370B (zh) * 2007-04-18 2014-06-25 基石制药公司 硫辛酸衍生物
CA2684479C (en) * 2007-04-18 2017-11-14 Cornerstone Pharmaceuticals, Inc. Amine salts of lipoic acid derivative and use thereof in the treatment of cancer
KR20110025168A (ko) * 2008-04-04 2011-03-09 로버트 쇼어 약학적 조성물
WO2011005311A1 (en) * 2009-07-07 2011-01-13 Robert Shorr Pharmaceutical composition
JP2019021063A (ja) 2017-07-18 2019-02-07 京セラドキュメントソリューションズ株式会社 印刷対象データ転送システム及び画像形成装置

Also Published As

Publication number Publication date
IL239512A0 (en) 2015-08-31
JP2016504331A (ja) 2016-02-12
IL239512B (en) 2020-08-31
CA2895029A1 (en) 2014-06-26
JP6395724B2 (ja) 2018-09-26
US20150322103A1 (en) 2015-11-12
EP2934542A4 (en) 2016-08-10
WO2014098926A1 (en) 2014-06-26
US20200331931A1 (en) 2020-10-22
AU2013364387B2 (en) 2018-07-19
CN105142643A (zh) 2015-12-09
HK1216619A1 (zh) 2016-11-25
CN105142643B (zh) 2021-09-03
US20180273551A1 (en) 2018-09-27
AU2013364387A1 (en) 2015-07-16
EP2934542A1 (en) 2015-10-28
BR112015014327A2 (pt) 2020-01-28

Similar Documents

Publication Publication Date Title
MD20140112A2 (ro) Analogi carba-nucleozidici 2'-substituiţi pentru tratamentul antiviral
EA201490272A1 (ru) Новые 4-пиперидинильные соединения для применения в качестве ингибиторов танкиразы
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
GEP20207102B (en) Sulfonamides as modulators of sodium channels
EA201500536A1 (ru) Триазолопиразин
PH12016500225A1 (en) Novel quinoline-substituted compound
NZ703162A (en) Heterocyclic modulators of lipid synthesis
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
IN2014CN04530A (es)
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
IN2014DN00090A (es)
MX342924B (es) Nuevos compuestos disustituidos de 3,4-diamino-3-ciclobuteno-1,2-d iona para uso en el tratamiento de patologias mediadas por quimiocinas.
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
BR112014014877A2 (pt) derivados da 1,5-naftiridina e inibidores do melk contendo os mesmos
BR112015030431A2 (pt) formulação de liberação modificada
IN2014DN05972A (es)
MX2015007885A (es) Compuestos farmaceuticos.
IN2013DN02555A (es)
MX2019011265A (es) Derivados del acido acetico azaindol y su uso como moduladores de receptor de prostaglandina d2.
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
MA37999B1 (fr) Dérivés de macrolide, leur préparation et leur utilisation thérapeutique
PH12015502703A1 (en) Pharmaceutical compositions
MX2016011900A (es) Derivados de acido azaindol-acetico y su uso como moduladores del receptor de prostaglandina d2.
MA37879B1 (fr) Forme amorphe stabilisée d'agomélatine, procédé pour sa préparation et compositions pharmaceutiques la contenant
WO2014045046A3 (en) Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen